After ASCO, Whither ImClone?
CHICAGO — Where does ImClone Systems(IMCL - Cramer’s Take - Stockpickr) stock price go from here?
That’s the most pressing question on many biotech investors’ minds as Monday trading looms after a very busy weekend of new Erbitux clinical data at the American Society of Clinical Oncology (ASCO) annual meeting.
(more…)